Discover why Eli Lilly and Company is set for a strong 2024 with a robust pipeline, solid financials, and strategic growth ...

Johnson & Johnson follows Eli Lilly in spending billions on U.S. manufacturing after President Donald Trump threatened major ...

Chinese Commerce Minister Wang Wentao said Friday that China remained steadfast in its commitment to expanding ...

Eli Lilly and Company, Gilead Sciences, and D-Wave Quantum are the three Pharmaceutical stocks to watch today, according to ...

Rajya Sabha member Milind Deora has criticised the launch of Mounjaro in India. The weight-loss drug, developed by US-based ...

Eli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.

Artificial intelligence can help. The stories below highlight startup companies that use AI to spot patterns that humans ...

President Donald Trump announced Friday that Boeing will build the Air Force’s future fighter jets, which the Pentagon says ...

While experts welcomed Mounjaro's launch, they stressed the importance of responsible prescribing to prevent misuse of the drug used for the treatment of type 2 diabetes and obesity.

After Trump threatened 25% tariffs on pharma imports, J&J became the latest pharma company to announce investments in the U.S.

There is a laundry list of companies that have market capitalizations of more than $100 billion that look like buys ...

How GLP-1 drugs, regulatory concerns, and more factors are shaping the sector. Plus, 3 undervalued healthcare stocks.